Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study used as the comparative drug (epoetin beta) will assess the efficacy and safety of
subcutaneous R744 in renal anemia patients on Predialysis.